{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T04:15:53Z","timestamp":1697343353745},"reference-count":24,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2012,5,23]],"date-time":"2012-05-23T00:00:00Z","timestamp":1337731200000},"content-version":"vor","delay-in-days":22,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Internal Medicine Journal"],"published-print":{"date-parts":[[2012,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background:\u2002<\/jats:bold> Leukaemic transformation (LT) is rare in the natural history of Philadelphia(Ph) chromosome\u2010negative myeloproliferative disorders (MPD), and has a dismal prognosis. Little literature is available on Asian patients.<\/jats:p><jats:p><jats:bold>Aims:\u2002<\/jats:bold> The aim of this study is to report a single institution experience of Asian patients who developed acute leukaemia after being diagnosed and treated for Ph chromosome\u2010negative MPDs, and to compare the findings of this series with similar studies from the literature.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> Patients were recruited from the MPD registry of Singapore General Hospital, Department of Hematology. Clinical data including treatment modalities and duration of use in myeloproliferative phase, latency to LT, characteristics of leukaemia, chemotherapy administered and survival after LT were examined.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> Over a 29\u2010year period from 1980 to 2009, there were 22 Asian patients with LT of Ph chromosome\u2010negative MPD of which four had polycythaemia vera (PV), nine had essential thrombocythaemia (ET), seven had myelofibrosis (MF) and two had unspecified MPD at diagnosis. Primary treatment modality was Hydroxyurea (HU) during MPD phase. Median latency to LT was 14\u2003years for PV, 10\u2003years for ET and 1\u2003year for MF. Median age at LT diagnosis was 67.5\u2003years. Nine patients had complex cytogenetics, with abnormalities of chromosomes 5 and 7 being common.<\/jats:p><jats:p>Overall, median survival was 2\u2003months after LT. Eight patients who received induction chemotherapy had a median survival of 2.5\u2003months. Survival was independent of MPD type and treatment administered. None received stem cell transplantation.<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> LT of Ph chromosome\u2010negative MPD is rare and uniformly fatal. Despite chemotherapy, survival was poor, and patients succumbed to refractory disease and infections. Asian patients did not have a more favourable outcome. It remains to be investigated whether upfront stem cell transplant may be a treatment option.<\/jats:p>","DOI":"10.1111\/j.1445-5994.2011.02629.x","type":"journal-article","created":{"date-parts":[[2011,10,27]],"date-time":"2011-10-27T17:18:18Z","timestamp":1319735898000},"page":"513-517","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Leukaemic transformation of Philadelphia chromosome\u2010negative myeloproliferative neoplasms: are Asian patients different?"],"prefix":"10.1111","volume":"42","author":[{"given":"R.","family":"Cherian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. C.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,5,23]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21297"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-09-3426"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404500"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002770050555"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-07-2864"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02981937"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1159\/000204873"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20651"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdp422"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.2.616"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-02-138230"},{"key":"e_1_2_6_13_2","first-page":"29","article-title":"Experience of the Polycythemia Vera Study with essential thrombocythemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment","volume":"34","author":"Murphy S","year":"1997","journal-title":"Semin Hematol"},{"key":"e_1_2_6_14_2","first-page":"177","article-title":"Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group","volume":"23","author":"Murphy S","year":"1986","journal-title":"Semin Hematol"},{"key":"e_1_2_6_15_2","first-page":"339","article-title":"Diagnosis and classification of the polycythemias","volume":"12","author":"Berlin NI","year":"1975","journal-title":"Semin Hematol"},{"key":"e_1_2_6_16_2","first-page":"132","article-title":"Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols","volume":"23","author":"Berk PD","year":"1986","journal-title":"Semin Hematol"},{"issue":"1","key":"e_1_2_6_17_2","first-page":"87","article-title":"The diagnostic criteria of polycythaemia rubra vera","volume":"22","author":"Pearson TC","year":"1996","journal-title":"Leuk Lymphoma"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200004273421706"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0037-1963(01)90133-7"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-04-1199"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1995.tb01621.x"},{"key":"e_1_2_6_22_2","first-page":"6","article-title":"A very long\u2010term evolution of polycythemia vera: an analysis of 318 patients initially treated by phlebotomy or 32P between 1969 and 1981","volume":"34","author":"Najean Y","year":"1997","journal-title":"Semin Hematol"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428190009089438"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1986.4.3.325"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8652(199905)61:1<10::AID-AJH3>3.0.CO;2-I"}],"container-title":["Internal Medicine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1445-5994.2011.02629.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1445-5994.2011.02629.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T01:36:12Z","timestamp":1697333772000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1445-5994.2011.02629.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["10.1111\/j.1445-5994.2011.02629.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1445-5994.2011.02629.x","archive":["Portico"],"relation":{},"ISSN":["1444-0903","1445-5994"],"issn-type":[{"value":"1444-0903","type":"print"},{"value":"1445-5994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5]]},"assertion":[{"value":"2012-05-23","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}